ERBB2 and breast cancer: We have previously shown in HER2 overexpressing breast cancer cell lines that DHA, by reducing the expression levels of the phosphorylated form of TCTP, enhances the response to treatment with drugs as doxorubicin, cisplatin and trastuzumab.